Prescription Monitoring Program

Since March 29, 2009, the Iowa Prescription Monitoring Program (PMP) has provided authorized prescribers and pharmacists with information regarding their patients’ use of controlled substances and is used as a tool in determining appropriate prescribing and treatment of patients without fear of contributing to a patient’s abuse of or dependence on addictive drugs or diversion of those drugs to illicit use. Iowa licensed pharmacies, both in-state and nonresident pharmacies, are required to report to the Iowa PMP all Schedule II, III, IV and V controlled substances and opioid antagonists (e.g., Narcan® or naloxone) dispensed by the pharmacy to ambulatory patients.  As of May 12, 2021, Iowa pharmacies are also required to report all OTC (non-prescription) Schedule V (e.g., codeine containing cough syrups) sold to patients.  

Please see the frequently asked questions link for additional information.  

General PMP Frequently Asked Questions (FAQs)

A patient interested in obtaining a copy of their PMP report may do so using the following form:  Patient's Request for PMP Information

Prescription Monitoring Program Annual Report to the Governor and Iowa Legislature:

Printed from the Iowa Board of Pharmacy website on June 20, 2021 at 3:52am.